Chromogranin - A and its role in the pathogenesis of diabetes mellitus

Chromogranina A i jej rola w patogenezie cukrzycy

Zoltan Herold, Marton Doleschall, Annamaria Kovesdi, A. Patócs, Aniko Omogyi

Research output: Contribution to journalArticle

Abstract

Chromogranin A is a member of the granin glycoprotein family that is expressed by the endocrine and neuroendocrine cells of different organs. Intracellularly, chromogranin A contributes to the regulation of secretion and gives several cleavage products after secretion. Some of its cleavage products modify the hormone functions in autocrine and paracrine ways, while the functions of others have not been fully understood yet. Serum chromogranin A level is most prominently used in neuroendocrine tumour diagnostics. In addition, recent studies have suggested that chromogranin A and some of its cleavage products (pancreastatin and WE-14) also play important roles in the pathogenesis of the various forms of diabetes mellitus, but their exact mechanisms still need to be clarified. Higher chromogranin A, pancreastatin, and WE-14 levels have been reported in type 1, type 2, and gestational diabetic patients compared to healthy controls. A notable connection has been inferred through the observation that type 1 diabetes mellitus is not at all or rarely developed in chromogranin A gene-knockout, non-obese diabetic model mice compared to non-knockout, non-obese diabetic mice. Pancreastatin inhibits insulin release in various cell and animal models, and WE-14 serves as an autoantigen for both CD4+ and CD8+ beta cell-destructive diabetogenic T-cell clones in type 1 diabetes. Chromogranin A contributes to the pathogenesis of diabetes mellitus according to the available literature. The current findings facilitate further investigation to unravel the deeper relationships between this glycoprotein and diabetes.

Original languageEnglish
Pages (from-to)598-610
Number of pages13
JournalEndokrynologia Polska
Volume69
Issue number5
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Chromogranin A
Diabetes Mellitus
Inbred NOD Mouse
Type 1 Diabetes Mellitus
Glycoproteins
Chromogranins
Neuroendocrine Cells
Gene Knockout Techniques
Endocrine Cells
Neuroendocrine Tumors
Autoantigens
Animal Models
Clone Cells
Hormones
Insulin
T-Lymphocytes
Serum

Keywords

  • chromogranin A
  • diabetes mellitus
  • diabetes mellitus type 1
  • diabetes mellitus type 2
  • gestational diabetes
  • mice inbred NOD
  • pancreastatin
  • WE-14

ASJC Scopus subject areas

  • Endocrinology

Cite this

Chromogranin - A and its role in the pathogenesis of diabetes mellitus : Chromogranina A i jej rola w patogenezie cukrzycy. / Herold, Zoltan; Doleschall, Marton; Kovesdi, Annamaria; Patócs, A.; Omogyi, Aniko.

In: Endokrynologia Polska, Vol. 69, No. 5, 01.01.2018, p. 598-610.

Research output: Contribution to journalArticle

Herold, Zoltan ; Doleschall, Marton ; Kovesdi, Annamaria ; Patócs, A. ; Omogyi, Aniko. / Chromogranin - A and its role in the pathogenesis of diabetes mellitus : Chromogranina A i jej rola w patogenezie cukrzycy. In: Endokrynologia Polska. 2018 ; Vol. 69, No. 5. pp. 598-610.
@article{5724ac21d4004ee498cba16d8afd999f,
title = "Chromogranin - A and its role in the pathogenesis of diabetes mellitus: Chromogranina A i jej rola w patogenezie cukrzycy",
abstract = "Chromogranin A is a member of the granin glycoprotein family that is expressed by the endocrine and neuroendocrine cells of different organs. Intracellularly, chromogranin A contributes to the regulation of secretion and gives several cleavage products after secretion. Some of its cleavage products modify the hormone functions in autocrine and paracrine ways, while the functions of others have not been fully understood yet. Serum chromogranin A level is most prominently used in neuroendocrine tumour diagnostics. In addition, recent studies have suggested that chromogranin A and some of its cleavage products (pancreastatin and WE-14) also play important roles in the pathogenesis of the various forms of diabetes mellitus, but their exact mechanisms still need to be clarified. Higher chromogranin A, pancreastatin, and WE-14 levels have been reported in type 1, type 2, and gestational diabetic patients compared to healthy controls. A notable connection has been inferred through the observation that type 1 diabetes mellitus is not at all or rarely developed in chromogranin A gene-knockout, non-obese diabetic model mice compared to non-knockout, non-obese diabetic mice. Pancreastatin inhibits insulin release in various cell and animal models, and WE-14 serves as an autoantigen for both CD4+ and CD8+ beta cell-destructive diabetogenic T-cell clones in type 1 diabetes. Chromogranin A contributes to the pathogenesis of diabetes mellitus according to the available literature. The current findings facilitate further investigation to unravel the deeper relationships between this glycoprotein and diabetes.",
keywords = "chromogranin A, diabetes mellitus, diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, mice inbred NOD, pancreastatin, WE-14",
author = "Zoltan Herold and Marton Doleschall and Annamaria Kovesdi and A. Pat{\'o}cs and Aniko Omogyi",
year = "2018",
month = "1",
day = "1",
doi = "10.5603/EP.a2018.0052",
language = "English",
volume = "69",
pages = "598--610",
journal = "Endokrynologia Polska",
issn = "0423-104X",
publisher = "Via Medica",
number = "5",

}

TY - JOUR

T1 - Chromogranin - A and its role in the pathogenesis of diabetes mellitus

T2 - Chromogranina A i jej rola w patogenezie cukrzycy

AU - Herold, Zoltan

AU - Doleschall, Marton

AU - Kovesdi, Annamaria

AU - Patócs, A.

AU - Omogyi, Aniko

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Chromogranin A is a member of the granin glycoprotein family that is expressed by the endocrine and neuroendocrine cells of different organs. Intracellularly, chromogranin A contributes to the regulation of secretion and gives several cleavage products after secretion. Some of its cleavage products modify the hormone functions in autocrine and paracrine ways, while the functions of others have not been fully understood yet. Serum chromogranin A level is most prominently used in neuroendocrine tumour diagnostics. In addition, recent studies have suggested that chromogranin A and some of its cleavage products (pancreastatin and WE-14) also play important roles in the pathogenesis of the various forms of diabetes mellitus, but their exact mechanisms still need to be clarified. Higher chromogranin A, pancreastatin, and WE-14 levels have been reported in type 1, type 2, and gestational diabetic patients compared to healthy controls. A notable connection has been inferred through the observation that type 1 diabetes mellitus is not at all or rarely developed in chromogranin A gene-knockout, non-obese diabetic model mice compared to non-knockout, non-obese diabetic mice. Pancreastatin inhibits insulin release in various cell and animal models, and WE-14 serves as an autoantigen for both CD4+ and CD8+ beta cell-destructive diabetogenic T-cell clones in type 1 diabetes. Chromogranin A contributes to the pathogenesis of diabetes mellitus according to the available literature. The current findings facilitate further investigation to unravel the deeper relationships between this glycoprotein and diabetes.

AB - Chromogranin A is a member of the granin glycoprotein family that is expressed by the endocrine and neuroendocrine cells of different organs. Intracellularly, chromogranin A contributes to the regulation of secretion and gives several cleavage products after secretion. Some of its cleavage products modify the hormone functions in autocrine and paracrine ways, while the functions of others have not been fully understood yet. Serum chromogranin A level is most prominently used in neuroendocrine tumour diagnostics. In addition, recent studies have suggested that chromogranin A and some of its cleavage products (pancreastatin and WE-14) also play important roles in the pathogenesis of the various forms of diabetes mellitus, but their exact mechanisms still need to be clarified. Higher chromogranin A, pancreastatin, and WE-14 levels have been reported in type 1, type 2, and gestational diabetic patients compared to healthy controls. A notable connection has been inferred through the observation that type 1 diabetes mellitus is not at all or rarely developed in chromogranin A gene-knockout, non-obese diabetic model mice compared to non-knockout, non-obese diabetic mice. Pancreastatin inhibits insulin release in various cell and animal models, and WE-14 serves as an autoantigen for both CD4+ and CD8+ beta cell-destructive diabetogenic T-cell clones in type 1 diabetes. Chromogranin A contributes to the pathogenesis of diabetes mellitus according to the available literature. The current findings facilitate further investigation to unravel the deeper relationships between this glycoprotein and diabetes.

KW - chromogranin A

KW - diabetes mellitus

KW - diabetes mellitus type 1

KW - diabetes mellitus type 2

KW - gestational diabetes

KW - mice inbred NOD

KW - pancreastatin

KW - WE-14

UR - http://www.scopus.com/inward/record.url?scp=85055671070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055671070&partnerID=8YFLogxK

U2 - 10.5603/EP.a2018.0052

DO - 10.5603/EP.a2018.0052

M3 - Article

VL - 69

SP - 598

EP - 610

JO - Endokrynologia Polska

JF - Endokrynologia Polska

SN - 0423-104X

IS - 5

ER -